Co-Diagnostics, Inc.
CODX
$0.332
-$0.0232-6.53%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -11.03M | -9.70M | -7.60M | -9.31M | -14.68M |
| Total Depreciation and Amortization | 357.10K | 351.20K | 338.30K | 330.60K | 312.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 713.90K | 879.50K | 1.75M | 1.01M | 8.42M |
| Change in Net Operating Assets | 1.73M | 1.24M | 304.60K | -515.30K | 1.16M |
| Cash from Operations | -8.23M | -7.23M | -5.20M | -8.49M | -4.78M |
| Capital Expenditure | -73.00K | -174.40K | -98.60K | -402.30K | -464.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 339.00K | 4.34M | -3.94M | 17.08M | 10.08M |
| Cash from Investing | 266.00K | 4.17M | -4.04M | 16.67M | 9.62M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 103.90K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -159.70K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 103.90K | -- | -- | -- | -159.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.86M | -3.06M | -9.24M | 8.18M | 4.68M |